Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial
Park KH et al. Diabetes Res Clin Prac 20184 142: 335–344. doi: 10.1016/j.diabres.2018.06.002
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.